BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Çekiç, O.
Right arrow Articles by Kayaalp, S O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Çekiç, O.
Right arrow Articles by Kayaalp, S O.
Br J Ophthalmol 1999;83:1183-1185 ( October )

Scientific correspondence

Penetration of topical, oral, and combined administered ofloxacin into the subretinal fluid Osman Çekiça, Cosar Batmana, Ümit Yasarb, Yüksel Totana, Nursabah E Bascib, Atilla Bozkurtb, Orhan Zilelioglua, S Oguz Kayaalpb

a SSK Ankara Eye Hospital, Department of Vitreoretinal Surgery, Ankara, Turkey, b Hacettepe University, Faculty of Medicine Department of Pharmacology, Ankara, Turkey

Correspondence to: Osman Çekiç, MD, 54 Basak Sokak, No 7, 06660 Kucukesat Ankara, Turkey

Accepted for publication 25 June 1999

AIMS---To assess the subretinal fluid (SRF) levels of ofloxacin following topical, oral or combined administration.
METHODS---31 patients undergoing conventional retinal reattachment surgery were randomly assigned to three groups. Nine patients received topical ofloxacin, 11 patients received oral ofloxacin, and the other 11 patients received combined administration. Collected SRF samples were analysed for drug level by using high performance liquid chromatography.
RESULTS---SRF drug levels after oral and combined administration were significantly higher than that after topical administration (p=0.0002 and p=0.0002, respectively) while there was no significant difference between oral and combined administration (p=0.0844).
CONCLUSIONS---Ocular bioavailability of ofloxacin in SRF after oral and combined administration is equivalent. The addition of oral ofloxacin to topical therapy increased drug SRF penetration sixfold.


© 1999 by British Journal of Ophthalmology



This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
O. Cekic, C. Batman, U. Yasar, N. E Basci, O. Zilelioglu, and A. Bozkurt
Subretinal fluid levels of topical, oral, and combined administered ciprofloxacin in humans
Br. J. Ophthalmol., September 1, 2000; 84(9): 1061 - 1063.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 by the BMJ Publishing Group Ltd.